Arcus Biosciences Inc (RCUS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RCUS | NMRA | ANIP | ||
| Company | Arcus Biosciences Inc | Neumora Therapeutics Inc | ANI Pharma Inc | ||
| Price Information | |||||
| Exchange | NYSE | NASDAQ | NASDAQ | ||
| Open | 15.70 | 9.23 | 66.96 | ||
| High | 15.80 | 9.27 | 67.87 | ||
| Low | 15.31 | 8.84 | 66.78 | ||
| Last | 15.50 | 9.22 | 67.11 | ||
| Change | unch | +0.12 | +0.59 | ||
| % Change | unch | +1.32% | +0.89% | ||
| Volume | 455,120 | 1,073,400 | 126,600 | ||
| 20-Day Average Volume | 525,210 | 631,845 | 122,845 | ||
| Previous Close | 15.50 | 9.10 | 66.52 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 15.83 | 11.23 | 66.21 | ||
| 20-Day Raw Stochastic | 39.55% | 6.53% | 69.29% | ||
| 20-Day Relative Strength | 44.82% | 30.88% | 56.48% | ||
| Weighted Alpha | -23.33 | -42.89 | +62.23 | ||
| Today's Opinion | 72% Sell | N/A | 88% Buy | ||
| Previous Opinion | 72% Sell | N/A | 88% Buy | ||
| Last Month's Opinion | 40% Buy | N/A | 72% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +5.23% since 04/25/24 | +1.77% since 04/25/24 | +3.33% since 04/25/24 | ||
| Low | 14.59 on 04/26/24 | 8.82 on 04/26/24 | 64.68 on 04/26/24 | ||
| High | 16.38 on 05/01/24 | 9.74 on 04/29/24 | 67.87 on 05/02/24 | ||
| 1-Month | |||||
| %Chg | -12.53% since 04/02/24 | -33.04% since 04/02/24 | +0.58% since 04/02/24 | ||
| Low | 14.10 on 04/19/24 | 8.82 on 04/26/24 | 64.20 on 04/19/24 | ||
| High | 18.06 on 04/04/24 | 14.95 on 04/09/24 | 68.40 on 04/05/24 | ||
| 3-Month | |||||
| %Chg | +3.61% since 02/02/24 | -39.97% since 02/02/24 | +21.09% since 02/02/24 | ||
| Low | 14.10 on 04/19/24 | 8.82 on 04/26/24 | 54.62 on 02/13/24 | ||
| High | 20.31 on 02/27/24 | 21.00 on 03/08/24 | 70.81 on 03/25/24 | ||
| 6-Month | |||||
| %Chg | -1.59% since 11/02/23 | -15.57% since 11/02/23 | +7.27% since 11/02/23 | ||
| Low | 12.95 on 11/13/23 | 8.82 on 04/26/24 | 48.20 on 12/08/23 | ||
| High | 20.31 on 02/27/24 | 21.00 on 03/08/24 | 70.81 on 03/25/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 1,409,772 | 1,451,022 | 1,402,175 | ||
| Shares Outstanding, K | 90,953 | 159,453 | 21,079 | ||
| Annual Sales | 117,000,000 | 0 | 486,820,000 | ||
| Annual Net Income | -307,000,000 | -235,930,000 | 18,780,000 | ||
| Last Quarter Sales | 31,000,000 | 0 | 131,650,000 | ||
| Last Quarter Net Income | -81,000,000 | -108,730,000 | 1,160,000 | ||
| 60-Month Beta | 0.91 | N/A | 0.80 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -1.08 on 02/21/24 | -0.71 on 03/07/24 | 1.00 on 02/29/24 | ||
| Latest Earnings Date | 05/08/24 | 06/06/24 | 05/10/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 17.10 | ||